BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions: Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease Interventions: Drug: Belumosudil; Drug: Fluticasone; Drug: Azithromycin; Drug: Prednisone Sponsors: Dana-Farber Cancer Institute; Sanofi; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions: Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease Interventions: Drug: Belumosudil; Drug: Fluticasone; Drug: Azithromycin; Drug: Prednisone; Drug: Montelukast Sponsors: Dana-Farber Cancer Institute; Sanofi; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma
Condition: Asthma Interventions: Drug: QVM149; Drug: Salmeterol Xinafoate / Fluticasone Propionate; Drug: Placebo to QVM149; Drug: Placebo to Salmeterol Xinafoate / Fluticasone Propionate; Drug: Run-In Medication; Drug: Rescue Medication; Device: Concept 1 Device; Device: Girohaler Sponsor: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials
